JPRN-UMIN000052077已完成Unknown
Development and usability evaluation of a decision aid for couples unsure about stepping up infertility treatment. - Development and usability evaluation of a decision aid for couples unsure about stepping up infertility treatment.
Tokyo Healthcare University0 个研究点目标入组 22 人开始时间: 2023年9月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Unable to obtain written consent
研究者
相似试验
进行中（未招募）
不适用
Evaluating the usability, acceptability and impact of a gamification/mindfulness etool for young peopleThe experience of stress & distress in young people.Mental Health - Other mental health disordersACTRN12615001001583Young and Well Cooperative Research Centre270
招募中
Unknown
Development of a website for family/friends of adults with depressioCarer mental healthMental Health - Studies of normal psychology, cognitive function and behaviourMental Health - DepressionDepressionACTRN12624000864527Deakin University30
已完成
不适用
The evaluation of usability, acceptability and immediate outcomes from the use of smartphone application for neck pain self-management in smartphone users with neck paieck painNeck painSmartphone applicationNeck pain self managementSelf managementAlternative therapyTCTR20190124003Graduate School, Khon Kaen University100
尚未招募
不适用
A Study to Assess How Well the MonitorMe Device Works in Detecting Known Heart Rhythm and Rate Irregularities in Patients With a Need for Cardiac Monitoring, and to Assess How User-friendly it is for the Patient.ArrhythmiasCardiovascular - Other cardiovascular diseasesACTRN12613000819729Infobionic40
进行中（未招募）
1 期
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapychildren aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC)-GHD-Turner Syndrome-small for gestational age-chronic renal insufficiencyEUCTR2009-017387-16-FRovo Nordisk Pharmaceutique S.A.S